VPR-254: an inhibitor of ROR-gamma T with potential utility for the treatment of inflammatory bowel disease

Leo R. Fitzpatrick*, Jeff Small, Robert O’Connell, George Talbott, Gordon Alton, Jim Zapf

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'VPR-254: an inhibitor of ROR-gamma T with potential utility for the treatment of inflammatory bowel disease'. Together they form a unique fingerprint.

Medicine & Life Sciences